|
CA2231509C
(en)
*
|
1995-09-11 |
2008-07-08 |
Osteoarthritis Sciences, Inc. |
Protein tyrosine kinase inhibitors for treating osteoarthritis
|
|
IL119069A0
(en)
|
1996-08-14 |
1996-11-14 |
Mor Research Applic Ltd |
Pharmaceutical composition comprising tyrphostins
|
|
DE19845372A1
(de)
*
|
1998-10-02 |
2000-04-20 |
Gruenenthal Gmbh |
Verwendung von Katecholderivaten als Proteinaseninhibitoren
|
|
DK1157019T3
(da)
|
1998-12-17 |
2003-07-14 |
Hoffmann La Roche |
4-alkenyl- (og alkynyl-)oxindoler som inhibitorer af cyklinafhængige kinaser, især CDK2
|
|
CA2354591A1
(en)
|
1998-12-17 |
2000-06-22 |
F. Hoffmann-La Roche Ag |
4-aryloxindoles as inhibitors of jnk protein kinases
|
|
US6153634A
(en)
|
1998-12-17 |
2000-11-28 |
Hoffmann-La Roche Inc. |
4,5-azolo-oxindoles
|
|
WO2000035921A1
(en)
|
1998-12-17 |
2000-06-22 |
F. Hoffmann-La Roche Ag |
4,5-pyrazinoxindoles as protein kinase inhibitors
|
|
MXPA01007099A
(es)
|
1999-01-13 |
2002-03-27 |
Univ New York State Res Found |
Metodo novedoso para disenar inhibidores de la proteina cinasa.
|
|
US7070936B1
(en)
|
1999-01-13 |
2006-07-04 |
The Research Foundation Of State University Of New York |
Method for designing protein kinase inhibitors
|
|
EP1200127B1
(en)
*
|
1999-07-21 |
2008-06-25 |
Omeros Corporation |
Solutions and methods for inhibition of pain, inflammation and cartilage degradation
|
|
US6313310B1
(en)
|
1999-12-15 |
2001-11-06 |
Hoffmann-La Roche Inc. |
4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles
|
|
EP1782800B1
(en)
*
|
2000-01-24 |
2013-12-18 |
Genzyme Corporation |
Methods for detecting JAK3 inhibitors
|
|
JP5512909B2
(ja)
*
|
2000-01-24 |
2014-06-04 |
ジェンザイム・コーポレーション |
Ｊａｋ／ｓｔａｔ経路阻害剤およびその使用
|
|
AU2001246850A1
(en)
*
|
2000-04-06 |
2001-10-23 |
Kyowa Hakko Kogyo Co. Ltd. |
Diagnostics and remedies for rheumatoid arthritis
|
|
US7067550B2
(en)
*
|
2000-11-03 |
2006-06-27 |
Massachusetts Institute Of Technology |
Treatments for neurotoxicity in Alzheimer's Disease
|
|
WO2002035987A2
(en)
*
|
2000-11-03 |
2002-05-10 |
Massachusetts Institute Of Technology |
METHODS FOR IDENTIFYING TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE CAUSED BY β-AMYLOID PEPTIDES
|
|
EP1408980A4
(en)
|
2001-06-21 |
2004-10-20 |
Ariad Pharma Inc |
NEW QUINAZOLINES AND THEIR USE
|
|
US7005445B2
(en)
*
|
2001-10-22 |
2006-02-28 |
The Research Foundation Of State University Of New York |
Protein kinase and phosphatase inhibitors and methods for designing them
|
|
US7129225B2
(en)
*
|
2001-10-22 |
2006-10-31 |
The Research Foundation Of State University Of New York |
Protection against and treatment of hearing loss
|
|
WO2003075943A2
(en)
*
|
2002-03-06 |
2003-09-18 |
The Medical Research And Education Trust |
Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising wogonin, isoliquiritigenin and/or coumestrol
|
|
US6924285B2
(en)
|
2002-03-30 |
2005-08-02 |
Boehringer Ingelheim Pharma Gmbh & Co. |
Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
|
|
GB0309850D0
(en)
|
2003-04-30 |
2003-06-04 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
WO2005003765A1
(en)
*
|
2003-06-30 |
2005-01-13 |
Astrazeneca Ab |
Isothermal titration calorimetry assays
|
|
GB0326459D0
(en)
|
2003-11-13 |
2003-12-17 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
WO2006007664A1
(en)
*
|
2004-07-22 |
2006-01-26 |
Genomics Research Partners Pty Ltd |
Agents and methods for diagnosing osteoarthritis
|
|
US8697139B2
(en)
|
2004-09-21 |
2014-04-15 |
Frank M. Phillips |
Method of intervertebral disc treatment using articular chondrocyte cells
|
|
US7947676B2
(en)
|
2004-12-14 |
2011-05-24 |
Astrazeneca Ab |
Pyrazolo[3,4-d]pyrimidine compounds as antitumor agents
|
|
DE102005005274A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Peter Heger |
Verwendung von Hydroxystilben-haltigen Wirkstoffen zur Prävention und Behandlung chronisch-entzündlicher Erkrankungen
|
|
JP2009508918A
(ja)
|
2005-09-20 |
2009-03-05 |
アストラゼネカ アクチボラグ |
癌治療のためのｅｒｂＢ受容体チロシンキナーゼ阻害剤としての４−（１Ｈ−インダゾール−５−イル］アミノ）キナゾリン化合物
|
|
JP5137818B2
(ja)
*
|
2006-03-20 |
2013-02-06 |
生化学工業株式会社 |
関節リウマチの処置剤
|
|
US7838542B2
(en)
*
|
2006-06-29 |
2010-11-23 |
Kinex Pharmaceuticals, Llc |
Bicyclic compositions and methods for modulating a kinase cascade
|
|
EP1921070A1
(de)
|
2006-11-10 |
2008-05-14 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
|
|
WO2008095847A1
(de)
|
2007-02-06 |
2008-08-14 |
Boehringer Ingelheim International Gmbh |
Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
|
WO2009026705A1
(en)
*
|
2007-08-24 |
2009-03-05 |
The University Of Western Ontario |
Method of diagnosing and treating osteoarthritis
|
|
WO2009098061A1
(de)
|
2008-02-07 |
2009-08-13 |
Boehringer Ingelheim International Gmbh |
Spirocyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
|
WO2009138781A1
(en)
|
2008-05-13 |
2009-11-19 |
Astrazeneca Ab |
Fumarate salt of 4- (3-chloro-2-fluoroanilino) -7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin- 4-yl] oxy}quinazoline
|
|
CN101396369B
(zh)
*
|
2008-08-07 |
2010-12-01 |
杜宁 |
槐角苷的制药应用
|
|
US8648191B2
(en)
|
2008-08-08 |
2014-02-11 |
Boehringer Ingelheim International Gmbh |
Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
|